Abstract:Parkinson's disease (PD) is a common neurodegenerative disease characterized by progressive loss of midbrain dopaminergic neurons with unknown etiology. MPP+ (1-methyl-4-phenylpyridinium) is the active metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which induces Parkinson's-like syndromes in humans and animals. MPTP/MPP+ treatment produces selective dopaminergic neuronal degeneration, therefore, these agents are commonly used to study the pathogenesis of PD. However, the mechanisms of their toxicity have not been elucidated. In order to gain insights into MPP+-induced neurotoxicity, a gene expression microarray study was performed using a midbrain-derived dopaminergic neuronal cell line, MN9D. Utilizing a two-color reference design, Agilent mouse oligonucleotide microarrays were used to examine relative gene expression changes in MN9D cells treated with 40 μM MPP+ compared with controls. Bioinformatics tools were used for data evaluation. Briefly, raw data were imported into the NCTR ArrayTrack database, normalized using a Lowess method and data quality was assessed. The Student's t-test was used to determine significant changes in gene expression (set as p < 0.05, fold change >1.5). Gene Ontology for Function Analysis (GOFFA) and Ingenuity Pathway Analysis were employed to analyze the functions and roles of significant genes in biological processes. Of the 51 significant genes identified, 44 were present in the GOFFA or Ingenuity database. These data indicate that multiple pathways are involved in the underlying mechanisms of MPP+-induced neurotoxicity, including apoptosis, oxidative stress, iron binding, cellular metabolism, and signal transduction. These data also indicate that MPP+-induced toxicity shares common molecular mechanisms with the pathogenesis of PD and further pathway analyses will be conducted to explore these mechanisms.

Differential protein expression induced by low-concentration N-methyl-N′-nitro-N-nitrosoguanidine in FL cells using two-dimensional gel electrophoresis

Differential Nuclear Proteomes in Response to N-Methyl-N '-Nitro-n-nitrosoguanidine Exposure

Proteomic Analysis of Cellular Responses to Low Concentration N‐methyl‐N′‐nitro‐N‐nitrosoguanidine in Human Amnion FL Cells

Altered Expression of Zinc Finger Proteins, ADAMs, and Integrin‐related Proteins Following Treatment of Cultured Human Cells with a Low Concentration of N‐methyl‐N′‐nitro‐N‐nitrosoguanidine

Proteomic Profiling for Cellular Responses to Different Concentrations of N-Methyl-N '-Nitro-n-nitrosoguanidine

Proteomic Analysis of Different Temporal Expression Patterns Induced by N-Methyl-N′-nitro-N-nitrosoguanidine Treatment

Quantitative and subcellular localization analysis of the nuclear isoform dUTP pyrophosphatase in alkylating agent-induced cell responses

Study on cellular gene response to low concentration of MNNG in human amnion FL cells by high throughput real-time fluorescent PCR

Dutp Pyrophosphatase, Its Appearance in Extracellular Compartment May Serve As a Potential Biomarker for N-methyl-N'-nitro-N-nitrosoguanidine Exposure in Mammalian Cells.

N-methyl-N'-nitro- N-nitrosoguanidine Induces the Phosphorylation of Histone H2AX in CHL Cells

Activation of JNK/SAPK Pathway in Vero Cells Induced by N-methyl-N'-nitro-N-nitrosoguanidine

Low Concentration N-methyl-N′-nitro-N-nitrosoguanidine Activates DNA Polymerase-Β Expression Via Cyclic-Amp-protein Kinase A-cAMP Response Element Binding Protein Pathway

ATR–CHK1–E2F3 Signaling Transactivates Human Ribonucleotide Reductase Small Subunit M2 for DNA Repair Induced by the Chemical Carcinogen MNNG

Response of Human DNA Polymerase Ι Promoter to N-methyl-N′-nitro-N-nitrosoguanidine

Low Concentration MNNG Inhibition of JNK/SAPK is Independent of a Nuclear Signal While MNNG Activation of P38mapk May Depend on a Nuclear Signal

Interferon Regulatory Factor 1 Transactivates Expression of Human DNA Polymerase Η in Response to Carcinogen N-Methyl-N′-nitro-N-nitrosoguanidine

Gene Expression Profiling of MPP+-treated MN9D Cells: A Mechanism of Toxicity Study

N-methyl-N′-nitro-N-nitrosoguanidine Interferes with the Epidermal Growth Factor Receptor-Mediated Signaling Pathway

Involvement of ATM/ATR-p38 MAPK Cascade in MNNG Induced G1-S Arrest

Pre-heat Shock Protects CHL Cells from the Genotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine

The Effects of N-methyl-N′-nitro-N-nitrosoguanidine on Cell Cycle Progression in Human Bronchial Epithelial(16hbe) Cells